NCT05794815View on ClinicalTrials.gov

Modulation of Gut Microbiota by Probiotic in Children With Respiratory Symptoms

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Respiratory Infection (for Example, Pneumonia, Bronchitis)
Interventions
DIETARY_SUPPLEMENT

Probiotic

Bifidobacterium infantis YLGB-1496 at 1x10 log CFU/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Intervention consists of daily administration of 2g of maltodextrin, administered daily for 12-weeks)

Trial Locations (1)

56000

RECRUITING

UKM Medical Centre, Cheras

All Listed Sponsors
collaborator

National University of Malaysia

OTHER

lead

Min-Tze LIONG

OTHER